findmyKOL
Clinical trialNCT04587830Active, not recruitingPhase 2Interventional

ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme

SponsorPolaris GroupEnrollment100Glioblastoma Multiforme (GBM)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Chonnam National University Hwasun Hospital

    Hwasun-gun, Jeollanam-do, South Korea

  • Seoul National University Hospital

    Seoul, Jongno-gu, South Korea

  • Seoul St. Mary'S Hospital, the Catholic University of Korea

    Seoul, Seocho-gu, South Korea

  • Severance Hospital Yonsei University

    Seoul, Seodaemun-gu, South Korea

  • Seoul National University Bundang Hospital

    Gyeonggi-do, Seongnam, South Korea

Taiwan
  • Chang Gung-Medical Foundation-Keelung (cgmf-Kl)

    Keelung, Anle Dist, Taiwan

  • Chang Gung Memorial Hospital, Linkou Branch

    Taoyuan, Guishan Dist, Taiwan

  • Chang Gung Medical Foundation-Kaohsiung

    Kaohsiung City, Niaosong Dist, Taiwan

  • Mackay Memorial Hospital-Tamsui Branch

    New Taipei City, Tamsui Dist, Taiwan

  • National Taiwan University Hospital

    Taipei, Zhongzheng Dist, Taiwan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Sept 2020
Primary completion
28 Feb 2027
Completion
30 May 2027
Last update posted
26 Aug 2025
Registered enrollment
100
Registry id
NCT04587830

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.